Security key
82835W108
ARS Pharmaceuticals, Inc. - Common Stock (SPRY)
CUSIP: 82835W108
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 94,099,513
- Total 13F value
- $755,807,496
- Share change
- +3,913,561
- Put/Call ratio
- 29%
- SEC-reported price per share
- $8.03
- Number of holders
- 200
- Value change
- +$10,864,887
- Number of buys
- 92
- Number of sells
- 81
- Shares outstanding
- 98,457,811
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
200
Top holders
10
SPRY full security history
Ownership snapshot
Full 13F holder table
ARS Pharmaceuticals, Inc. SEC filings
ARS Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
James E. Flynn
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F
13D/G
3/4/5
Lead comparable stake: 11%
13D/G row: RA CAPITAL MANAGEMENT, L.P.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
11%
Rubric Capital Management LP
8.1%
James E. Flynn
7.8%
ORBIMED ADVISORS LLC
8.4%
DEERFIELD MANAGEMENT COMPANY, L.P.
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
Company
|
11%
from 13D/G
|
$126,530,382
10,860,977 shares
|
— | 31 Dec 2025 |
| Rubric Capital Management LP |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$72,230,000
6,200,000 shares
|
— | 31 Dec 2025 |
| James E. Flynn |
3/4/5
13D/G
10%+ Owner · Deerfield Management Company, L.P.
|
7.8%
from 13D/G
|
$180,437,416
9,774,508 shares
|
— | 27 Jun 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
8.4%
|
$96,561,142
8,288,510 shares
|
— | 31 Dec 2025 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
7.6%
|
$87,419,410
7,503,812 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
5.2%
|
$59,243,944
5,085,317 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
200
Shares
94,099,513
Rows available
200
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
200
Q1 2026 holders
200
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|